ID: ALA5273352

Max Phase: Preclinical

Molecular Formula: C20H40N4O11

Molecular Weight: 512.56

Associated Items:

Representations

Canonical SMILES:  C[C@@H](O)[C@H]1O[C@H](O[C@H]2[C@H](O[C@@H]3O[C@H](CNCCO)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C20H40N4O11/c1-6(26)16-14(30)13(29)10(23)19(33-16)34-17-8(22)4-7(21)11(27)18(17)35-20-15(31)12(28)9(32-20)5-24-2-3-25/h6-20,24-31H,2-5,21-23H2,1H3/t6-,7-,8+,9-,10-,11+,12-,13-,14+,15-,16-,17-,18-,19-,20+/m1/s1

Standard InChI Key:  HYIBBJNQVZQIKH-GBIAXBPOSA-N

Associated Targets(Human)

Premature termination codon 106 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Escherichia coli 133304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bacillus subtilis 32866 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DNA 609 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 512.56Molecular Weight (Monoisotopic): 512.2694AlogP: -6.64#Rotatable Bonds: 9
Polar Surface Area: 268.62Molecular Species: BASEHBA: 15HBD: 11
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.17CX Basic pKa: 9.59CX LogP: -6.27CX LogD: -10.91
Aromatic Rings: 0Heavy Atoms: 35QED Weighted: 0.13Np Likeness Score: 1.46

References

1. Guchhait S, Khononov A, Pieńko T, Belakhov V, Baasov T..  (2023)  Balancing Nonsense Mutation Readthrough and Toxicity of Designer Aminoglycosides for Treatment of Genetic Diseases.,  14  (6): [PMID:37312846] [10.1021/acsmedchemlett.3c00089]

Source